Contributions of multimodal imaging

Yazar: Oyen, Wim JG
Yayımlandı Cancer Imaging (2014)

Consensus Procedures in Oncological Imaging: The Case of Prostate Cancer

Yazar: Fanti, Stefano, Oyen, Wim, Lalumera, Elisabetta
Yayımlandı Cancers (Basel) (2019)

FIAU: From reporter gene imaging to imaging of bacterial proliferation

Yazar: Boerman, Otto C, Laverman, Peter, Oyen, Wim JG
Baskı/Yayın Bilgisi 2012

Predictive and prognostic value of FDG-PET

Yazar: de Geus-Oei, Lioe-Fee, Oyen, Wim J.G.
Baskı/Yayın Bilgisi 2008

Nuclear medicine imaging and therapy of neuroendocrine tumours

Yazar: Gotthardt, Martin, Dijkgraaf, Ingrid, Boerman, Otto C, Oyen, Wim J G
Baskı/Yayın Bilgisi 2006

Gastroparesis in patients with inactive Crohn's disease: a case series

Yazar: Kristinsson, Jón O, Hopman, Wim PM, Oyen, Wim JG, Drenth, Joost PH
Baskı/Yayın Bilgisi 2007

Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with (111)In in HEPES and MES buffer

Yazar: Brom, Maarten, Joosten, Lieke, Oyen, Wim JG, Gotthardt, Martin, Boerman, Otto C
Baskı/Yayın Bilgisi 2012

Radiolabelled peptides for oncological diagnosis

Yazar: Laverman, Peter, Sosabowski, Jane K., Boerman, Otto C., Oyen, Wim J. G.
Baskı/Yayın Bilgisi 2012

Peritoneal Carcinomatosis of Colorectal Origin: Incidence and Current Treatment Strategies

Yazar: Koppe, Manuel J., Boerman, Otto C., Oyen, Wim J. G., Bleichrodt, Robert P.
Baskı/Yayın Bilgisi 2006

Peritoneal Carcinomatosis of Colorectal Origin: Standard of Care

Yazar: Koppe, Manuel J., Boerman, Otto C., Oyen, Wim J. G., Bleichrodt, Robert P.
Baskı/Yayın Bilgisi 2006

(68)Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET

Yazar: Brom, Maarten, Oyen, Wim J. G., Joosten, Lieke, Gotthardt, Martin, Boerman, Otto C.
Baskı/Yayın Bilgisi 2010

Radiolabelled GLP-1 analogues for in vivo targeting of insulinomas

Yazar: Brom, Maarten, Joosten, Lieke, Oyen, Wim J.G., Gotthardt, Martin, Boerman, Otto C.
Yayımlandı Contrast Media Mol Imaging (2012)

FDG-PET/CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality Treatment

Yazar: Quak, Elske, Kovacs, Iringo, Oyen, Wim J. G., van der Graaf, Winette T. A.
Yayımlandı Nucl Med Mol Imaging (2015)

Methodological considerations in quantification of oncological FDG PET studies

Yazar: Vriens, Dennis, Visser, Eric P., de Geus-Oei, Lioe-Fee, Oyen, Wim J. G.
Baskı/Yayın Bilgisi 2009

Multi-modality nuclear medicine imaging: artefacts, pitfalls and recommendations

Yazar: van Dalen, Jorn A., Vogel, Wouter V., Corstens, Frans H.M., Oyen, Wim J.G.
Baskı/Yayın Bilgisi 2007

Can FDG PET predict radiation treatment outcome in head and neck cancer? Results of a prospective study

Yazar: Schinagl, Dominic A. X., Span, Paul N., Oyen, Wim J., Kaanders, Johannes H. A. M.
Baskı/Yayın Bilgisi 2011

Immunotherapy response evaluation with (18)F-FDG-PET in patients with advanced stage renal cell carcinoma

Yazar: Gilles, Rozemarie, de Geus-Oei, Lioe-Fee, Mulders, Peter F. A., Oyen, Wim J. G.
Baskı/Yayın Bilgisi 2011

EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems

Yazar: Kaalep, Andres, Sera, Terez, Oyen, Wim, Krause, Bernd J., Chiti, Arturo, Liu, Yan, Boellaard, Ronald
Yayımlandı Eur J Nucl Med Mol Imaging (2017)

Radiolabeled antibodies in renal cell carcinoma

Yazar: Stillebroer, Alexander B., Oosterwijk, Egbert, Oyen, Wim J.G., Mulders, Peter F.A., Boerman, Otto C.
Baskı/Yayın Bilgisi 2007

Antibody therapy in renal cell carcinoma

Yazar: Oosterwijk, Egbert, Boerman, Otto C., Oyen, Wim J. C., Old, Lloyd J., Mulders, Peter F. A.
Baskı/Yayın Bilgisi 2008